Biggest News Aggregation in the World
📰 Acer News

Page 21 - Acer News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Acer. Real-time updates on events, politics, business and more.

ITI develops laptop, micro personal computer called 'SMAASH' with 'international standards'

As per the exchange filing, all SMAASH products have obtained essential certifications, including BIS (Bureau of Indian Standards), ROHS (Restriction of Hazardous Substances), BEE (Bureau of Energy Efficiency), CE (European Conformity), and FCC (Federal Communication Commission).
Rajesh Rai Bureau Of Indian Standards Ministry Of Communication Communication Commission Bureau Of Energy Efficiency Technology For Education

Acer Therapeutics (NASDAQ:ACER) Stock Rating Lowered by HC Wainwright

HC Wainwright cut shares of Acer Therapeutics (NASDAQ:ACER – Free Report) from a buy rating to a neutral rating in a research report released on Tuesday morning, Marketbeat reports. HC Wainwright also issued estimates for Acer Therapeutics’ Q3 2023 earnings at ($0.12) EPS, Q4 2023 earnings at ($0.06) EPS and FY2024 earnings at $0.00 EPS. […]
Knott Davidm Jr Roth Mkm Geode Capital Management Renaissance Technologies Vanguard Group Inc Acer Therapeutics Company Profile

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Acer Therapeutics (NASDAQ:ACER) Receives Neutral Rating from Roth Capital

Roth Capital reaffirmed their neutral rating on shares of Acer Therapeutics (NASDAQ:ACER – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $1.50 price target on the biopharmaceutical company’s stock. Separately, Roth Mkm cut Acer Therapeutics from a buy rating to a neutral rating and set a $1.50 target price […]
Roth Mkm Geode Capital Management Meridian Wealth Management Renaissance Technologies Acer Therapeutics Inc Hunter Associates Investment Management

Roth Mkm Downgrades Acer Therapeutics (NASDAQ:ACER) to Neutral

Roth Mkm lowered shares of Acer Therapeutics (NASDAQ:ACER – Free Report) from a buy rating to a neutral rating in a research note published on Friday, MarketBeat reports. Roth Mkm currently has $1.50 price target on the biopharmaceutical company’s stock. Acer Therapeutics Trading Down 10.9 % Acer Therapeutics stock opened at $1.14 on Friday. The […]
Roth Mkm Meridian Wealth Management Armistice Capital Renaissance Technologies Acer Therapeutics Company Profile Acer Therapeutics Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science